Azobenzenes
Medchemexpress LLC 2-(3-oxo-1-phenyl-3-(4-(trifluoromethyl)phenyl)propyl)malonic acid | 1221962-86-2 | 98.3% | 25 MG
PS210 is a small-molecule activator of 3-phosphoinositide-dependent protein kinase-1 (PDK1) that engages the PIF-binding pocket and is used as a research reagent to study PDK1 signaling.
- Potent and selective PDK1 activator for research use.
- CAS number 1221962-86-2 for unambiguous identification.
- Molecular formula C19H15F3O5 and molecular weight 380.31 g·mol⁻¹.
- High purity (≈98%) suitable for biochemical assays.
- Supplied as a solid powder; recommended storage at -20°C for long-term stability.
- Available in small research pack sizes (25 mg) for laboratory studies.
eMolecules 1262771-85-6 | AstaTech | (4-ETHYLTHIAZOL-2-YL)METHANAMINE DIHYDROCHLORIDE | 1g | 718080323 | AT34437 | 95 | MFCD09864312 | 215.14 | C6H12Cl2N2S
Ambeed | 4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-34-dihydrobenzo[f][14]oxazepin-5(2H)-one hydrochloride | 1mg | 534568661 | A642597 | 1448754-43-5 | MFCD30377215 | 451.830 | C21H17ClF3N3O3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC 4-hydroxy-2-methyl-1,1-dioxo-N-(1,3-thiazol-2-yl)-1lambda6,2-benzothiazine-3-carboxamide | 34042-85-8 | MFCD00866053 | 95.0% | 337.37 g/mol | C13H11N3O4S2 | 5 MG
Sudoxicam is a reversible, orally active cyclooxygenase (COX) antagonist from the enol-carboxamide class of non-steroidal anti-inflammatory drugs (NSAIDs). Provided for laboratory research use only, it exhibits anti-inflammatory, anti-edema, and antipyretic activities and is supplied as a characterized solid for use in in vitro and in vivo pharmacology studies.
- Reversible COX antagonist with anti-inflammatory, anti-edema, and antipyretic activity.
- Enol-carboxamide class NSAID commonly used in pharmacology research.
- Supplied as a solid suitable for dissolution in common laboratory solvents, such as DMSO.
- Characterized molecular weight and formula support reproducible experimental design.
- Available in small research quantities appropriate for dose-response and in vivo studies.
- Intended for research use only; not for human or clinical use.
Medchemexpress LLC PR5-LL-CM01 | 1005307-86-7 | 98.4% | 401.51 | 50 MG
PR5-LL-CM01 is a potent protein arginine methyltransferase 5 (PRMT5) inhibitor with an IC50 of 7.5 μM. It exhibits anti-tumor activities and demonstrates efficacy in inhibiting cancer cells while showing low toxicity in normal cells.
- Has IC50 values ranging from 2-4 μM in PDAC cells (PANC1, MiaPaCa2, and AsPC1) and 10-11 μM in CRC cells (HT29, HCT116, and DLD1).
- Strongly inhibits colony-forming ability in both PANC1 and HT29 cells.
- Inhibits NF-κB activation and its target gene expression in PDAC and CRC cells.
- Significantly decreases TNFα and IL8 expression in both PANC1 and HT29 cells (at 0-15 μM).
- Shows significant anti-tumor effects in PANC1 and HT29 xenografted mice in vivo (20 mg/kg; i.p.; 3 times per week) without visibly affecting their body weight.
eMolecules 2374958-85-5 | Ambeed | (4S4S)-44-Diisopropyl-11-di-m-tolyl-4455-tetrahydro-1H1H-22-biimidazole | 100mg | 714083376 | A1501171 | 402.586 | C26H34N4
Pharmablock | 2-methoxy-4-methyl-1H-pyrimidin-6-one | 25mg | 784547466 | PBT8844 | 55996-28-6 | MFCD16988156 | 140.142 | C6H8N2O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC D5D-IN-326 | 1236767-85-3 | 99.9% | 473.27 | C17H11F8N3O4 | 5 MG
D5D-IN-326 is a selective, orally active delta-5 desaturase (D5D) inhibitor (CAS 1236767-85-3) with reported nanomolar potency in enzymatic and cell-based assays and demonstrated activity in preclinical metabolic disease models. The compound is supplied for research use in multiple formats and sizes and is characterized by high purity and defined storage stability.
- Selective inhibitor of delta-5 desaturase with nanomolar potency.
- Reduces insulin resistance and body weight in preclinical models.
- High purity (99.9%) for reliable experimental results.
- Available as powder and solution formats for flexible dosing.
- Stable under recommended storage conditions for long-term use.
- Supplied in small research quantities suitable for in vitro and in vivo studies.
Medchemexpress LLC Orismilast | 1353546-86-7 | 99.9% | 510.29 g·mol⁻¹ | C19H15Cl2F2NO7S | 5 MG
Orismilast is an orally active, selective phosphodiesterase 4 (PDE4) inhibitor used in preclinical research on inflammatory diseases. It demonstrates potent activity against PDE4B and PDE4D subtype splice variants and is supplied as a high-purity research compound.
- Selective phosphodiesterase 4 (PDE4) inhibitor.
- Orally active compound suitable for inflammatory disease research.
- Potent inhibition of PDE4B and PDE4D subtype splice variants.
- High purity solid supplied in a 5 mg package.
- Molecular weight 510.29 g·mol⁻¹; formula C19H15Cl2F2NO7S.
eMolecules 1452458-86-4 | Medchem Express | Nacubactam | 5mg | 628192271 | HY-109008 | 324.31 | C9H16N4O7S
Medchem Express | DSR-141562 | 5mg | 532149366 | HY-136569 | 2007975-22-4 | 414.429 | C19H25F3N4O3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
eMolecules 104-23-4 | 4'-Aminoazobenzene-4-sulphonic acid | Combi-Blocks | MFCD00035778 | 277.300 | C12H11N3O3S | 97.000 | Nc1ccc(cc1)\N=N\c1ccc(cc1)S(O)(=O)=O | 1g | 205402053
4'-Aminoazobenzene-4-sulphonic acid | Combi-Blocks | 104-23-4 | MFCD00035778 | 277.300 | C12H11N3O3S | 97.000 | Nc1ccc(cc1)\N=N\c1ccc(cc1)S(O)(=O)=O | 1g | 205402053
![eMolecules 12068-85-8 | Irondisulfide, 99.9% | ChemScene119.970 | FeS2 | 99.000 | [Fe+].S=[S-] | 5g | 601109816](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502483891.JPG-250.jpg)
eMolecules 12068-85-8 | Irondisulfide, 99.9% | ChemScene119.970 | FeS2 | 99.000 | [Fe+].S=[S-] | 5g | 601109816
Irondisulfide, 99.9% | ChemScene | 12068-85-8119.970 | FeS2 | 99.000 | [Fe+].S=[S-] | 5g | 601109816
eMolecules 655-86-7 | 2,3-DIAMINOPHENAZINE | AstaTech | MFCD00160693 | 210.240 | C12H10N4 | 0.000 | Nc1cc2nc3ccccc3nc2cc1N | 1g | 323610682
2,3-DIAMINOPHENAZINE | AstaTech | 655-86-7 | MFCD00160693 | 210.240 | C12H10N4 | 0.000 | Nc1cc2nc3ccccc3nc2cc1N | 1g | 323610682
Sigma Aldrich Fine Chemicals Biosciences Azobenzene 98% | 103-33-3 | MFCD00003022 | 25G
Azobenzene 98% | Purity: 98% | Mol Wt: 182.22 | 103-33-3 | MFCD00003022 | 25G
Sigma Aldrich Fine Chemicals Biosciences 4-(Phenylazo)diphenylamine 97% | 101-75-7 | MFCD00003023 | 5G
4-(Phenylazo)diphenylamine 97% | Purity: 97% | Mol Wt: 273.33 | 101-75-7 | MFCD00003023 | 5G
Selleck Chemical LLC Phycocyanobilin-5mg
Phycocyanobilin (PCB) is an open-chain tetrapyrrole chromophore covalently bonded to both polypeptide chains of C-Phycocyanin (C-PC), the most represented biliprotein of Spirulina platensis, the mechanisms by which it protected cells included the reduction of oxidative stress damage, which could contribute to its clinical efficacy for the treatment of neurodegenerative diseases.This product has poor solubility, animal experiments are available, cell experiments please choose carefully!
Medchemexpress LLC Nimbin | 5945-86-8 | 5 MG
Nimbin is an orally active intermediate limonoid found in Azadirachta. It prevents tau aggregation, increases cell viability, and effectively inhibits the envelope protein of the dengue virus. It possesses anti-inflammatory, antipyretic, antifungal, antihistamine, antiseptic, antioxidant, anti-cancer, and anti-viral properties, showing promise for research into neurodegenerative diseases and viral infections.
- Orally active intermediate limonoid
- Prevents tau aggregation and increases cell viability
- Effective inhibitor of the dengue virus envelope protein
- Anti-inflammatory, antipyretic, antifungal, antihistamine, antiseptic, antioxidant, anti-cancer, and anti-viral properties
- Promising for research of neurodegenerative diseases and viral infections